Hims & Hers' (HIMS 0. 67%) management team laid out jections for where they believe revenue and fit will be in 2030. *Stock prices used were the afternoon prices of June 27, 2025.
The was published on June 29, 2025. Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Hims & Hers Health.
The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for moting its services.
If you choose to through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.